Multidisciplinary Approaches to Managing AEs with Bispecifics

Opinion
Video

Dr Mohan engages with Nurse Goff, Dr Mann, and Nurse Brigle to explore effective multidisciplinary approaches for managing adverse events (AEs) associated with bispecific therapies and compares the AE profiles of talquetamab, teclistamab, and elranatamab, highlighting unique challenges and benefits.

Video content above is prompted by the following:

  • What multidisciplinary approaches have you found most effective in managing the diverse range of AEs associated with bispecific therapies?
  • Based on your experience, how do the AE profiles of talquetamab compare with those of other bispecific therapies like teclistamab or elranatamab?
  • Are there any unique challenges or benefits you’ve observed?

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
4 experts in this video
4 experts in this video
4 experts in this video
4 experts in this video
Image of a woman with light brown hair wearing glasses with a blue background
Image of a woman wearing glasses in front of a blue background
Image of a woman with glasses in front of a blue background
Image of a man in a suit smiling in front of an Oncology Nursing News background
Related Content